Cutaneous Melanoma – Page 6 – Melanoma Research Foundation

Press Release

FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...

4 Minute Read

Blogs Events Featured Melanoma News Press Release

December 23, 2023

Mechanisms of Macrophage Evasion in Residual Melan...

Medical Student Award – Jude Raj

1 Minute Read

December 23, 2023

Defining the dynamics of ICOS+ CD4 T cell response...

Medical Student Award – Megen Wittling

1 Minute Read

December 23, 2023

Targeting the eIF4F, Translation Initiation Comple...

The translation initiation complex (or TIC) is one of the last unexplored targets in cancer therapy or melanoma. Protein production is tightly controlled by a complex of fo...

1 Minute Read

December 19, 2023

NKT infiltration and rejection in melanomas

Current immunotherapies have dramatically improved clinical outcomes, but more than half of metastatic melanoma patients have poor responses and primary resistance. With ti...

1 Minute Read

December 19, 2023

TGFßi NK Cell Infusions in Patients with Melanoma...

Brain metastases remain a leading cause of death in patients with metastatic melanoma. One of the most exciting advances in the treatment of CNS metastases was combined che...

2 Minute Read

December 19, 2023

Targeting an adaptor function of CDK6 to enhance m...

Immunotherapy has been remarkably successful in the treatment of melanoma, but not all patients benefit from therapy and its effects is in most cases temporary, followed by...

1 Minute Read

December 19, 2023

Immunogenic landscape and therapeutic targeting of...

Many cancer immunotherapy patients fail to respond or progress after initially experiencing tumor regression. More than 25% of melanomas carry activating mutations in the d...

1 Minute Read

December 19, 2023

Targeting melanoma with engineered CD4+ T cells

Both helper CD4 T cells and killer CD8 T cells are known to be involved in immune responses to cancer. Helper CD4 T cells assist immune responses to cancer by enhancing the...

2 Minute Read

December 19, 2023

Deciphering the role of APRIL/TNFSF13 in melanoma-...

The overall survival of a subset of patients with melanoma drastically improved with a type of treatment called immunotherapy, which activates the body’s immune system to...

1 Minute Read

December 19, 2023

Evaluation of cutaneous immune related adverse eve...

The treatment of melanoma with checkpoint inhibitor (CPI) therapy has produced rapid and substantial gains in survival, and as a result, the indications for its use have st...

3 Minute Read